Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy

Objective: The prolonged usage of antiepileptic medicines has been linked to a reduction in bone mineral density (BMD), resulting in the risk of fracture. However, most evidence has been from western countries, predominantly in institutionalized patients. Furthermore, only a single antiepileptic dru...

Full description

Bibliographic Details
Main Authors: Damera Achyuth Kumar, Lubna Zafar, Hamid Ashraf, Ahmad Ghayas Ansari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Apollo Medicine
Subjects:
Online Access:http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=4;spage=213;epage=218;aulast=Kumar
_version_ 1811177498682064896
author Damera Achyuth Kumar
Lubna Zafar
Hamid Ashraf
Ahmad Ghayas Ansari
author_facet Damera Achyuth Kumar
Lubna Zafar
Hamid Ashraf
Ahmad Ghayas Ansari
author_sort Damera Achyuth Kumar
collection DOAJ
description Objective: The prolonged usage of antiepileptic medicines has been linked to a reduction in bone mineral density (BMD), resulting in the risk of fracture. However, most evidence has been from western countries, predominantly in institutionalized patients. Furthermore, only a single antiepileptic drug (AED) has been evaluated. This study explores the impact of AEDs on bone health in ambulatory patients from North India. Methodology: A hospital-based observational study on sixty adult patients with epilepsy. All patients were already on AED (valproic acid [VPA], levetiracetam, and phenytoin) either as monotherapy or polytherapy. The serum levels of calcium, phosphorus, alkaline phosphatase, albumin, 25 (OH) Vitamin D, and intact parathyroid hormone were estimated. BMD was assessed at the lumbar spine and femur using a dual-energy X-ray absorptiometry scan. Results: The mean age of patients was 32.75 ± 5.9 years. 56.7% of subjects were female, and 43.3% were male. 40% of patients were taking VPA. Both cytochrome P450 inducing and noninducing AED resulted in a decline in T-score at the lumbar spine (P < 0.01). The BMD declined significantly as the duration of AED intake was prolonged (P < 0.001). Conclusions: In some patients, the intake of AEDs is prolonged, even lifelong. People living with epilepsy are predisposed to falls, and the adverse effects of AED on bone metabolism over time compound the risk of fractures. Thus, the physician needs to monitor all patients on AED for bone health and advise early intervention.
first_indexed 2024-04-11T06:02:49Z
format Article
id doaj.art-2d518a1d9edf4fb995df140a1481eb41
institution Directory Open Access Journal
issn 0976-0016
2213-3682
language English
last_indexed 2024-04-11T06:02:49Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Apollo Medicine
spelling doaj.art-2d518a1d9edf4fb995df140a1481eb412022-12-22T04:41:35ZengWolters Kluwer Medknow PublicationsApollo Medicine0976-00162213-36822022-01-0119421321810.4103/am.am_71_22Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapyDamera Achyuth KumarLubna ZafarHamid AshrafAhmad Ghayas AnsariObjective: The prolonged usage of antiepileptic medicines has been linked to a reduction in bone mineral density (BMD), resulting in the risk of fracture. However, most evidence has been from western countries, predominantly in institutionalized patients. Furthermore, only a single antiepileptic drug (AED) has been evaluated. This study explores the impact of AEDs on bone health in ambulatory patients from North India. Methodology: A hospital-based observational study on sixty adult patients with epilepsy. All patients were already on AED (valproic acid [VPA], levetiracetam, and phenytoin) either as monotherapy or polytherapy. The serum levels of calcium, phosphorus, alkaline phosphatase, albumin, 25 (OH) Vitamin D, and intact parathyroid hormone were estimated. BMD was assessed at the lumbar spine and femur using a dual-energy X-ray absorptiometry scan. Results: The mean age of patients was 32.75 ± 5.9 years. 56.7% of subjects were female, and 43.3% were male. 40% of patients were taking VPA. Both cytochrome P450 inducing and noninducing AED resulted in a decline in T-score at the lumbar spine (P < 0.01). The BMD declined significantly as the duration of AED intake was prolonged (P < 0.001). Conclusions: In some patients, the intake of AEDs is prolonged, even lifelong. People living with epilepsy are predisposed to falls, and the adverse effects of AED on bone metabolism over time compound the risk of fractures. Thus, the physician needs to monitor all patients on AED for bone health and advise early intervention.http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=4;spage=213;epage=218;aulast=Kumarantiepileptic drugsbone metabolismbone mineral density
spellingShingle Damera Achyuth Kumar
Lubna Zafar
Hamid Ashraf
Ahmad Ghayas Ansari
Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
Apollo Medicine
antiepileptic drugs
bone metabolism
bone mineral density
title Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
title_full Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
title_fullStr Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
title_full_unstemmed Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
title_short Alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
title_sort alteration in bone metabolism and bone mineral density with chronic antiepileptic drug therapy
topic antiepileptic drugs
bone metabolism
bone mineral density
url http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=4;spage=213;epage=218;aulast=Kumar
work_keys_str_mv AT dameraachyuthkumar alterationinbonemetabolismandbonemineraldensitywithchronicantiepilepticdrugtherapy
AT lubnazafar alterationinbonemetabolismandbonemineraldensitywithchronicantiepilepticdrugtherapy
AT hamidashraf alterationinbonemetabolismandbonemineraldensitywithchronicantiepilepticdrugtherapy
AT ahmadghayasansari alterationinbonemetabolismandbonemineraldensitywithchronicantiepilepticdrugtherapy